Ftse Mib
34.371,44
1,13%
DAX
18.309,55
0,76%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.999,99
1,32%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Innate Pharma SA (IPHA) Innate Pharma SA (IPHA) Notizie

Innate Pharma SA

IPHA
2,49
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 12:31:35
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/5/202407:00BWInnate Pharma organise une conférence téléphonique pour..
15/4/202407:00BWInnate Pharma to Hold Its Annual General Meeting of..
10/4/202407:00BWInnate Pharma présente des données d’efficacité précliniques..
09/4/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
05/4/202409:34BWInnate Pharma publie son Document D’enregistrement Universel..
21/3/202407:00BWInnate Pharma Reports Full Year 2023 Financial Results and..
19/3/202407:00BWInnate Pharma annonce sa participation à une prochaine..
14/3/202407:00BWInnate Pharma Announces Conference Call and Webcast for Full..
06/3/202407:00BWInnate Pharma: First Patient dosed in Phase 1/2 study of..
21/2/202407:00BWInnate Pharma Announces Its Participation to Upcoming..
17/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/1/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202407:00BWNouveau nombre d’actions et de droits de vote d’Innate..
05/1/202412:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202407:00BWInnate Pharma Announces U.S. FDA Lifts Partial Clinical Hold..
04/1/202406:59BWInnate Pharma renforce son équipe de direction et nomme deux..
20/12/202322:45EDGAR2Form F-3 - Registration statement by foreign private issuers
20/12/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202313:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202307:00BWInnate Pharma annonce la licence d’un quatrième NK Cell..
18/12/202307:00BWInnate Pharma Announces Leadership Change
11/12/202307:00BWInnate Pharma partage les résultats d’efficacité et de..
10/12/202307:00BWInnate Pharma Presents Positive Results From TELLOMAK Phase..
27/11/202307:00BWInnate Pharma to Host Virtual KOL Event on Lacutamab
14/11/202307:00BWInnate Pharma présente ses résultats financiers au troisième..
07/11/202307:00BWInnate Pharma organise une conférence téléphonique pour ses..
03/11/202311:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202307:00BWInnate Pharma annonce la présentation de nouvelles données..
27/10/202312:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202307:00BWInnate Pharma annonce sa participation à de prochaines..
19/10/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/10/202307:00BWInnate Pharma 2024 Financial Calendar
16/10/202307:00BWInnate Pharma Announces Abstracts Selected for ESMO Congress..
09/10/202307:00BWNouveau nombre d’actions et de droits de vote d’Innate..
05/10/202314:14DJNInnate Pharma Shares Fall Premarket on FDA Partial Study..
05/10/202307:00BWInnate Pharma annonce une mise à jour sur le programme..
22/9/202307:00BWInnate Pharma présente les données d’efficacité..
14/9/202312:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/9/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/9/202307:00BWInnate Pharma présente ses résultats financiers et l’avancée..
29/8/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202307:00BWInnate Pharma annonce sa participation à de prochaines..
10/8/202307:00BWProchain rendez-vous investisseurs d'Innate Pharma
11/7/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202307:00BWFirst Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical..
07/7/202312:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/7/202307:00BWNouveau nombre d’actions et de droits de vote d’Innate..
26/6/202307:00BWInnate Pharma : Traitement du premier patient dans l’essai..
Apertura: Min: Max:
Chiusura: 2,49

La tua Cronologia

NASDAQ
IPHA
Innate Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network